SOURCE: Cleveland BioLabs, Inc.

Cleveland BioLabs, Inc.

March 04, 2010 09:00 ET

Cleveland BioLabs Announces Annual Meeting

BUFFALO, NY--(Marketwire - March 4, 2010) -  Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company will hold its 2010 annual stockholders meeting on June 8, 2010 in Buffalo, NY for stockholders of record as of April 9, 2010. The Company will distribute proxy materials to all eligible stockholders.

About Cleveland BioLabs, Inc.
Cleveland BioLabs, Inc. is a drug discovery and development company leveraging its proprietary discoveries around programmed cell death to develop treatments for cancer and protection of normal tissues from exposure to radiation and other stresses. The Company has strategic partnerships with the Cleveland Clinic, Roswell Park Cancer Institute, ChemBridge Corporation and the Armed Forces Radiobiology Research Institute. To learn more about Cleveland BioLabs, Inc., please visit the company's website at http://www.cbiolabs.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Some of the factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 30, 2009.

Contact Information

  • Contact:
    Rachel Levine
    Director Corporate Development & Communications
    Cleveland BioLabs, Inc.
    T: (646) 284-9439
    E:rlevine@cbiolabs.com